Invention Grant
- Patent Title: Benzoimidazol-1,2-yl amides as Kv7 channel activators
- Patent Title (中): 苯并咪唑-1,2-基酰胺作为Kv7通道活化剂
-
Application No.: US14853815Application Date: 2015-09-14
-
Publication No.: US09481653B2Publication Date: 2016-11-01
- Inventor: Lynn Resnick , George T. Topalov , Steven A. Boyd , Justin K. Belardi , Charles A. Flentge , James S. Hale , Scott S. Harried , David A. Mareska , Kai Zhang
- Applicant: Knopp Biosciences LLC
- Applicant Address: US PA Pittsburgh
- Assignee: KNOPP BIOSCIENCES LLC
- Current Assignee: KNOPP BIOSCIENCES LLC
- Current Assignee Address: US PA Pittsburgh
- Agency: K&L Gates LLP
- Agent Louis C. Cullman; Robert W. Winn
- Main IPC: C07D235/30
- IPC: C07D235/30 ; C07D401/04 ; C07D401/12 ; C07D405/12 ; C07D413/04
Abstract:
Optionally substituted benzoimidazol-1,2-yl amides, such as compounds of Formula 1 or Formula 2, can be used to treat disorders associated with a Kv7 potassium channel activator. Compositions, medicaments, and dosage forms related to the treatment are also disclosed herein.
Public/Granted literature
- US20160075663A1 BENZOIMIDAZOL-1,2-YL AMIDES AS Kv7 CHANNEL ACTIVATORS Public/Granted day:2016-03-17
Information query
